---

---

Exhibit
12.2

302 CERTIFICATION

CERTIFICATION OF CHIEF
FINANCIAL OFFICER

I, Fabian Tenenbaum,
certify that:

1. I have reviewed this annual
report on Form 20-F of Syneron Medical Ltd.;

2. Based on my  knowledge,  this
report does not contain any untrue  statement  of a material  fact or omit to state a
material fact  necessary to make the  statements  made, in light of the  circumstances
under which such  statements  were made,  not  misleading  with respect to the period
 covered by this report;

3. Based on my knowledge,  the
financial statements,  and other financial information included in this report,  fairly
present in all material  respects the financial  condition,  results of operations and
cash flows of the company as of, and for, the periods presented in this report;

4.  The  registrant's  other
 certifying  officer(s)  and  I  are  responsible  for  establishing  and maintaining
 disclosure  controls  and  procedures  (as defined in Exchange  Act Rules  13a-15(e)
 and 15d-15(e) and internal  control over  financial  reporting (as defined in Exchange
Act  Rules13a-15(f) and 15d-15(f)) for the company and have:

|a. | designed
 such  disclosure  controls and  procedures,  or caused such  disclosure  controls and
       procedures to be designed under our supervision,  to ensure that material
 information relating        to the company, including its consolidated  subsidiaries,
 is made known to us by others within        those entities, particularly during the
period in which this report is being prepared;
|-- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|b. | designed
such internal control over financial  reporting,  or caused such internal control over
       financial  reporting to be designed  under our  supervision,  to provide
 reasonable  assurance        regarding the reliability of financial  reporting and the
 preparation of financial  statements        for external purposes in accordance with
generally accepted accounting principles;
|-- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|c. | evaluated
the effectiveness of the company's  disclosure  controls and procedures and presented
       in this  report  our  conclusions  about  the  effectiveness  of the  disclosure
 controls  and        procedures, as of the end of the period covered by this report
based on such evaluation; and
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|d. | disclosed
 in  this  report  any  change  in the  company's  internal  control  over  financial
       reporting  that occurred  during the period  covered by the annual  report that
has  materially        affected,  or is reasonably likely to materially  affect,  the
company's  internal control over        financial reporting; and
|-- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



---

---

5.  The  company's  other
 certifying  officer(s)  and I have  disclosed,  based  on our  most  recent evaluation
of internal  control over  financial  reporting,  to the  company's  auditors and the
audit committee of company's board of directors (or persons performing the equivalent
function):

|a. | all
 significant  deficiencies  and material  weaknesses in the design or operation of
internal        control  over  financial  reporting  which  are  reasonably  likely  to
 adversely  affect  the        company's ability to record, process, summarize and report
financial data; and
|-- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|b. | any
 fraud,   whether  or  not  material,   that  involves   management  or  other  employees
 who        have a significant role in the company's internal control over financial
reporting.
|-- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Date: June 15, 2007

|/s/ Fabian Tenenbaum
Fabian Tenenbaum, 
Chief Financial Officer |  | 
|----------------------------------------------------------------------------- |  | 

2

---

---